Significant Ownership of BB BIOTECH AG

Signature - Title
/s/ Christian Koch - Christian Koch/Signatory Authority
Location
Schaffhausen
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by BB BIOTECH AG.

Notify me when BB BIOTECH AG files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of BB BIOTECH AG

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ESPR Esperion Therapeutics, Inc. Common Stock 4.9% $8,821,598 -$227,500 9,694,064 -2.5% BB Biotech AG 04 Mar 2025
BDTX Black Diamond Therapeutics, Inc. Common Stock 4.8% $4,373,675 -$9,254,867 2,733,547 -68% BB Biotech AG 19 Mar 2025
SAGE Sage Therapeutics, Inc. Common Stock 1.9% $9,180,538 1,178,503 BB Biotech AG 13 Jan 2025
AGIO Agios Pharmaceuticals, Inc. Common Stock 0% $0 -$96,033,898 0 -100% BB Biotech AG 01 Jun 2025
MGNX MACROGENICS INC Common Stock 0% $0 -$15,292,143 0 -100% BB Biotech AG 01 Jun 2025

Schedules 13D/G Reported by BB BIOTECH AG:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.